Home/Filings/4/0001209191-21-045275
4//SEC Filing

Cancro Thomas 4

Accession 0001209191-21-045275

CIK 0001101680other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 12:39 PM ET

Size

8.4 KB

Accession

0001209191-21-045275

Insider Transaction Report

Form 4
Period: 2021-07-01
Cancro Thomas
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-07-01+10,00010,000 total
    Exercise: $20.90Exp: 2031-07-01Common Stock (10,000 underlying)
  • Award

    Restricted Stock Units

    2021-07-01+20,00020,000 total
    Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]These restricted stock units were granted pursuant to the issuer's 2017 Incentive Award Plan and will vest in four equal installments on July 1, 2022, 2023, 2024 and 2025, subject to the reporting person's continued employment with the issuer on each vesting date. Each restricted stock unit represents the right to receive one share of the issuer's common stock upon vesting.
  • [F2]These options were granted pursuant to the issuer's 2017 Incentive Award Plan and will vest over a four year vesting schedule as follows: 25% of the options will vest on July 1, 2022 and the remainder will vest in 36 equal monthly installments thereafter subject to the reporting person's continued employment with the issuer on each vesting date.

Issuer

DZS INC.

CIK 0001101680

Entity typeother

Related Parties

1
  • filerCIK 0001615513

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 12:39 PM ET
Size
8.4 KB